Hudson Bay Capital Management LP Avidity Biosciences, Inc. Transaction History
Hudson Bay Capital Management LP
- $21.9 Billion
- Q3 2024
A detailed history of Hudson Bay Capital Management LP transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 30,000 shares of RNA stock, worth $883,800. This represents 0.01% of its overall portfolio holdings.
Number of Shares
30,000Holding current value
$883,800% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding RNA
# of Institutions
254Shares Held
107MCall Options Held
224KPut Options Held
161K-
Price T Rowe Associates Inc Baltimore, MD10.6MShares$313 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.23MShares$272 Million0.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$254 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY8.13MShares$240 Million5.95% of portfolio
-
Wellington Management Group LLP Boston, MA7.03MShares$207 Million0.06% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $1.54B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...